- Home
- Publications
- Publication Search
- Publication Details
Title
Synaptic Vesicle Glycoprotein 2A: Features and Functions
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 16, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-28
DOI
10.3389/fnins.2022.864514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [ 11 C]UCB‐J
- (2022) Adam P. Mecca et al. Alzheimers & Dementia
- Imaging the effect of ketamine on synaptic density (SV2A) in the living brain
- (2022) Sophie E. Holmes et al. MOLECULAR PSYCHIATRY
- Assessment of test-retest reproducibility of [18F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A
- (2021) Songye Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT2A Receptor Density in the Pig Brain
- (2021) Nakul Ravi Raval et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of Aβ deposition and regional synaptic density in early Alzheimer’s disease: a PET imaging study with [11C]UCB-J
- (2021) Ryan S. O’Dell et al. Alzheimers Research & Therapy
- Cross-linking mass spectrometry uncovers protein interactions and functional assemblies in synaptic vesicle membranes
- (2021) Sabine Wittig et al. Nature Communications
- Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex
- (2021) Els F. Halff et al. BEHAVIOURAL BRAIN RESEARCH
- Comparison of [11C]UCB-J and [18F]FDG PET in Alzheimer’s disease: A tracer kinetic modeling study
- (2021) Ming-Kai Chen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ 11 C ] UCB‐J PET Imaging Study
- (2021) Katrine B. Andersen et al. MOVEMENT DISORDERS
- Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study
- (2021) Laura Michiels et al. NEUROIMAGE
- The pharmacokinetics of [18F]UCB-H revisited in the healthy non-human primate brain
- (2021) Sébastien Goutal et al. EJNMMI Research
- Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment
- (2021) Itzel Jatziri Contreras-García et al. Brain Sciences
- The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability
- (2021) Te-Yu Hung et al. Biomedicines
- Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
- (2021) Julian J Weiss et al. CLINICAL INFECTIOUS DISEASES
- Exercise protects synaptic density in a rat model of Parkinson's disease
- (2021) K.H. Binda et al. EXPERIMENTAL NEUROLOGY
- Changes in synaptic density in the subacute phase after ischemic stroke: A 11C-UCB-J PET/MR study
- (2021) Laura Michiels et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington’s Disease mice and post-mortem human HD brain
- (2021) Daniele Bertoglio et al. JOURNAL OF NUCLEAR MEDICINE
- In vivo evidence of lower synaptic vesicle density in schizophrenia
- (2021) Rajiv Radhakrishnan et al. MOLECULAR PSYCHIATRY
- Partial volume correction analysis for 11C-UCB-J PET studies of Alzheimer's disease
- (2021) Yihuan Lu et al. NEUROIMAGE
- Lower synaptic density is associated with psychiatric and cognitive alterations in obesity
- (2021) Ruth H. Asch et al. NEUROPSYCHOPHARMACOLOGY
- In vivo exploration of synaptic projections in frontotemporal dementia
- (2021) Eric Salmon et al. Scientific Reports
- The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and magnetic resonance spectroscopy brain imaging study
- (2021) Ellis Chika Onwordi et al. Translational Psychiatry
- Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory 11 C‐UCB‐J positron emission tomography study in humans
- (2021) Gustavo A. Angarita et al. ADDICTION BIOLOGY
- A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16
- (2021) Chao Zheng et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- All‐optical monitoring of excitation–secretion coupling demonstrates that SV2A functions downstream of evoked Ca 2+ entry
- (2021) Mazdak M. Bradberry et al. JOURNAL OF PHYSIOLOGY-LONDON
- In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease
- (2021) Mengfei Xiong et al. NEUROIMAGE
- Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease
- (2021) Aline Delva et al. NEUROLOGY
- α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease
- (2021) Kathrine Stokholm et al. Biomedicines
- Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson’s Disease
- (2021) Nakul Ravi Raval et al. Frontiers in Synaptic Neuroscience
- Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease
- (2021) Adam P. Mecca et al. NEUROBIOLOGY OF AGING
- Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2
- (2020) Zhengxin Cai et al. ACS Chemical Neuroscience
- Synaptic Changes in Parkinson Disease Assessed with in vivo Imaging
- (2020) David Matuskey et al. ANNALS OF NEUROLOGY
- Automated radiosynthesis of [11 C]UCB-J for imaging synaptic density by positron emission tomography
- (2020) Selena Milicevic Sephton et al. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
- Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
- (2020) Ellis Chika Onwordi et al. Nature Communications
- In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
- (2020) Adam P. Mecca et al. Alzheimers & Dementia
- An epilepsy-associated SV2A mutation disrupts synaptotagmin-1 expression and activity-dependent trafficking
- (2020) Callista B. Harper et al. JOURNAL OF NEUROSCIENCE
- Exploring with [18F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy
- (2020) Maria Elisa Serrano et al. MOLECULAR IMAGING AND BIOLOGY
- Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease
- (2020) Heather Wilson et al. MOVEMENT DISORDERS
- Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non‐human primate and human brain
- (2020) Katarina Varnäs et al. SYNAPSE
- In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET
- (2020) Majken B Thomsen et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Binding of the synaptic vesicle radiotracer [11C]UCB-J is unchanged during functional brain activation using a visual stimulation task
- (2020) Kelly Smart et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Simplified Quantification of 11C-UCB-J PET Evaluated in a Large Human Cohort
- (2020) Mika Naganawa et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical PET Studies of [11C]UCB-J Binding in Minipig Brain
- (2020) Majken Borup Thomsen et al. MOLECULAR IMAGING AND BIOLOGY
- Synaptic Loss in Primary Tauopathies Revealed by [ 11 C ] UCB‐J Positron Emission Tomography
- (2020) Negin Holland et al. MOVEMENT DISORDERS
- Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
- (2020) Aline Delva et al. MOVEMENT DISORDERS
- Distinct synaptic vesicle recycling in inhibitory nerve terminals is coordinated by SV2A
- (2020) Jae Ryul Bae et al. PROGRESS IN NEUROBIOLOGY
- Human adult and adolescent biodistribution and dosimetry of the synaptic vesicle glycoprotein 2A radioligand 11C-UCB-J
- (2020) Jason Bini et al. EJNMMI Research
- Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [ 11 C]UCB‐J positron emission tomography study
- (2020) Sjoerd J. Finnema et al. EPILEPSIA
- First-in-human evaluation of 18F-SynVesT-1, a novel radioligand for PET imaging of synaptic vesicle protein 2A
- (2020) Mika Naganawa et al. JOURNAL OF NUCLEAR MEDICINE
- Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
- (2020) Deepak Cyril D’Souza et al. MOLECULAR PSYCHIATRY
- Quantification of SV2A Binding in Rodent Brain Using [18F]SynVesT-1 and PET Imaging
- (2020) Pragalath Sadasivam et al. MOLECULAR IMAGING AND BIOLOGY
- PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats
- (2020) Majken B. Thomsen et al. NEUROBIOLOGY OF DISEASE
- A single‐center, open‐label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers
- (2019) Sjoerd J. Finnema et al. EPILEPSIA
- In vivo synaptic density imaging with 11C-UCB-J detects treatment effects of saracatinib (AZD0530) in a mouse model of Alzheimer’s disease.
- (2019) Takuya Toyonaga et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET
- (2019) Serrano et al. MOLECULES
- Differential expression of SV2A in hippocampal glutamatergic and GABAergic terminals during postnatal development
- (2019) América Vanoye-Carlo et al. BRAIN RESEARCH
- Synthesis and in vivo evaluation of [18F]UCB-J for PET imaging of synaptic vesicle glycoprotein 2A (SV2A)
- (2019) Songye Li et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Validation and noninvasive kinetic modeling of [11C]UCB-J PET imaging in mice
- (2019) Daniele Bertoglio et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Characterization of 3 PET tracers for Quantification of Mitochondrial and Synaptic function in Healthy Human Brain: 18F-BCPP-EF, 11C-SA-4503, 11C-UCB-J
- (2019) Ayla Mansur et al. JOURNAL OF NUCLEAR MEDICINE
- Validation of Parametric Methods for [11C]UCB-J PET Imaging Using Subcortical White Matter as Reference Tissue
- (2019) Nathalie Mertens et al. MOLECULAR IMAGING AND BIOLOGY
- Lower synaptic density is associated with depression severity and network alterations
- (2019) Sophie E. Holmes et al. Nature Communications
- In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography
- (2019) Christine Bastin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Assessment of a white matter reference region for 11C-UCB-J PET quantification
- (2019) Samantha Rossano et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain
- (2019) Julieta G. Mendoza-Torreblanca et al. NEUROSCIENCE
- Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A–Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity
- (2019) Shil Patel et al. MOLECULAR IMAGING AND BIOLOGY
- Increased Inflammation and Unchanged Density of Synaptic Vesicle Glycoprotein 2A (SV2A) in the Postmortem Frontal Cortex of Alzheimer’s Disease Patients
- (2019) Athanasios Metaxas et al. Frontiers in Cellular Neuroscience
- Preparation of 99m Tc-levetiracetam intranasal microemulsion as the first radiotracer for SPECT imaging of the Synaptic Vesicle Protein SV2A
- (2018) Hassan M. Rashed et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Crystal Structure of Botulinum Neurotoxin A2 in Complex with the Human Protein Receptor SV2C Reveals Plasticity in Receptor Binding
- (2018) Robert Gustafsson et al. Toxins
- Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
- (2018) Ming-Kai Chen et al. JAMA Neurology
- Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue
- (2018) Michel Koole et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers
- (2018) Cristian C. Constantinescu et al. MOLECULAR IMAGING AND BIOLOGY
- Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates
- (2018) Songye Li et al. ACS Chemical Neuroscience
- Differential expression of synaptic vesicle protein 2A after status epilepticus and during epilepsy in a lithium-pilocarpine model
- (2018) Itzel Jatziri Contreras-García et al. EPILEPSY & BEHAVIOR
- Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value
- (2018) Maria Elisa Serrano et al. MOLECULAR IMAGING AND BIOLOGY
- Kinetic evaluation and test–retest reproducibility of [11C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans
- (2017) Sjoerd J Finnema et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Pharmacokinetic Characterization of [18F]UCB-H PET Radiopharmaceutical in the Rat Brain
- (2017) Guillaume Becker et al. MOLECULAR PHARMACEUTICS
- Enabling Efficient Positron Emission Tomography (PET) Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) with a Robust and One-Step Radiosynthesis of a Highly Potent 18F-Labeled Ligand ([18F]UCB-H)
- (2016) Corentin Warnier et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain
- (2016) N. B. Nabulsi et al. JOURNAL OF NUCLEAR MEDICINE
- N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
- (2016) Guorui Yao et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- [11C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A
- (2016) Sergio Estrada et al. NUCLEAR MEDICINE AND BIOLOGY
- Dopamine synapse is a neuroligin-2–mediated contact between dopaminergic presynaptic and GABAergic postsynaptic structures
- (2016) Motokazu Uchigashima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging synaptic density in the living human brain
- (2016) Sjoerd J. Finnema et al. Science Translational Medicine
- N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
- (2016) Guorui Yao et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
- (2016) Jasmin Weisemann et al. Toxins
- Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy
- (2016) Catherine Menten-Dedoyart et al. PLoS One
- Synaptic vesicle glycoprotein 2A (SV2A) regulates kindling epileptogenesis via GABAergic neurotransmission
- (2016) Kentaro Tokudome et al. Scientific Reports
- Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking
- (2015) Elizabeth García-Pérez et al. EPILEPSIA
- Synaptic vesicle protein2A decreases in amygdaloid-kindling pharmcoresistant epileptic rats
- (2015) Jing Shi et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Phosphorylation of Synaptic Vesicle Protein 2A at Thr84 by Casein Kinase 1 Family Kinases Controls the Specific Retrieval of Synaptotagmin-1
- (2015) N. Zhang et al. JOURNAL OF NEUROSCIENCE
- Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [18F]UCB-H: First-in-Human Study
- (2015) F. Bretin et al. MOLECULAR IMAGING AND BIOLOGY
- Homozygous Mutation in Synaptic Vesicle Glycoprotein 2A Gene Results in Intractable Epilepsy, Involuntary Movements, Microcephaly, and Developmental and Growth Retardation
- (2015) Fatema J. Serajee et al. PEDIATRIC NEUROLOGY
- Exploring the Interaction of SV2A with Racetams Using Homology Modelling, Molecular Dynamics and Site-Directed Mutagenesis
- (2015) Joanna Lee et al. PLoS One
- Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations
- (2015) José Correa-Basurto et al. Frontiers in Cellular Neuroscience
- Discovery of Heterocyclic Nonacetamide Synaptic Vesicle Protein 2A (SV2A) Ligands with Single-Digit Nanomolar Potency: Opening Avenues towards the First SV2A Positron Emission Tomography (PET) Ligands
- (2014) Joël Mercier et al. ChemMedChem
- Hippocampal low-frequency stimulation increased SV2A expression and inhibited the seizure degree in pharmacoresistant amygdala-kindling epileptic rats
- (2014) Likun Wang et al. EPILEPSY RESEARCH
- Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses
- (2014) Christian Vogl et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter inSaccharomyces cerevisiae
- (2014) Marianna Madeo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of 18F-UCB-H as a Novel PET Tracer for Synaptic Vesicle Protein 2A in the Brain
- (2014) G. I. Warnock et al. JOURNAL OF NUCLEAR MEDICINE
- Radiosynthesis of 11C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression
- (2014) Hancheng Cai et al. ACS Medicinal Chemistry Letters
- Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E
- (2013) Stefan Mahrhold et al. BIOCHEMICAL JOURNAL
- Expression of SV2 isoforms during rodent brain development
- (2013) Julie Crèvecœur et al. BMC NEUROSCIENCE
- Inhibition of Ca2+-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs
- (2013) Saeko Harada et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Botulinum Neurotoxin Type A is Internalized and Translocated from Small Synaptic Vesicles at the Neuromuscular Junction
- (2013) Cesare Colasante et al. MOLECULAR NEUROBIOLOGY
- Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H
- (2013) Florian Bretin et al. EJNMMI Research
- Combining modelling and mutagenesis studies of synaptic vesicle protein 2A to identify a series of residues involved in racetam binding
- (2012) Jiye Shi et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Levetiracetam has an activity-dependent effect on inhibitory transmission
- (2012) Anna L. Meehan et al. EPILEPSIA
- Tetanus Toxin and Botulinum Toxin A Utilize Unique Mechanisms To Enter Neurons of the Central Nervous System
- (2012) Faith C. Blum et al. INFECTION AND IMMUNITY
- Glycosylation Is Dispensable for Sorting of Synaptotagmin 1 but Is Critical for Targeting of SV2 and Synaptophysin to Recycling Synaptic Vesicles
- (2012) Sung E. Kwon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice
- (2012) Kumar Venkatesan et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Low distribution of synaptic vesicle protein 2A and synaptotagimin-1 in the cerebral cortex and hippocampus of spontaneously epileptic rats exhibiting both tonic convulsion and absence seizure
- (2012) R. Hanaya et al. NEUROSCIENCE
- Antiepileptic effects of levetiracetam in a rodent neonatal seizure model
- (2012) Delia M. Talos et al. PEDIATRIC RESEARCH
- Novel Ganglioside-mediated Entry of Botulinum Neurotoxin Serotype D into Neurons
- (2011) Abby R. Kroken et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam
- (2011) Anna L. Meehan et al. JOURNAL OF NEUROPHYSIOLOGY
- Protein Quantification at the Single Vesicle Level Reveals That a Subset of Synaptic Vesicle Proteins Are Trafficked with High Precision
- (2011) S. A. Mutch et al. JOURNAL OF NEUROSCIENCE
- Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
- (2011) Amy Nowack et al. PLoS One
- Epilepsy Caused by an Abnormal Alternative Splicing with Dosage Effect of the SV2A Gene in a Chicken Model
- (2011) Marine Douaud et al. PLoS One
- Botulinum Neurotoxin D Uses Synaptic Vesicle Protein SV2 and Gangliosides as Receptors
- (2011) Lisheng Peng et al. PLoS Pathogens
- SV2 regulates neurotransmitter release via multiple mechanisms
- (2010) Amy Nowack et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Distribution of SV2C mRNA and protein expression in the mouse brain with a particular emphasis on the basal ganglia system
- (2010) D. Dardou et al. BRAIN RESEARCH
- Antiepileptogenic and anticonvulsive actions of levetiracetam in a pentylenetetrazole kindling model
- (2010) Yukihiro Ohno et al. EPILEPSY RESEARCH
- Effects of antiepileptic drugs on associative LTP-like plasticity in human motor cortex
- (2010) Tonio Heidegger et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Cotrafficking of SV2 and Synaptotagmin at the Synapse
- (2010) J. Yao et al. JOURNAL OF NEUROSCIENCE
- Synapse loss in dementias
- (2010) Ryan Clare et al. JOURNAL OF NEUROSCIENCE RESEARCH
- SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
- (2010) Felix L. Yeh et al. PLoS Pathogens
- Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling
- (2009) Yukihiro Ohno et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glycosylated SV2 and Gangliosides as Dual Receptors for Botulinum Neurotoxin Serotype F
- (2009) Zhuji Fu et al. BIOCHEMISTRY
- Large Structural Change in Isolated Synaptic Vesicles upon Loading with Neurotransmitter
- (2009) Kristi L. Budzinski et al. BIOPHYSICAL JOURNAL
- Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam
- (2009) Rafal M. Kaminski et al. EPILEPSIA
- Down-regulation Synaptic Vesicle Protein 2A in the Anterior Temporal Neocortex of Patients with Intractable Epilepsy
- (2009) Guibo Feng et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor
- (2009) Andreas Rummel et al. JOURNAL OF NEUROCHEMISTRY
- SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis
- (2009) W.-P. Chang et al. JOURNAL OF NEUROSCIENCE
- Visualization of SV2A conformations in situ by the use of Protein Tomography
- (2008) Berkley A. Lynch et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats
- (2008) Doru-Georg Margineanu et al. BRAIN RESEARCH BULLETIN
- Decreased expression of synaptic vesicle protein 2A, the binding site for levetiracetam, during epileptogenesis and chronic epilepsy
- (2008) Erwin A. van Vliet et al. EPILEPSIA
- Synaptic Vesicle Protein 2 Binds Adenine Nucleotides
- (2008) Jia Yao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons
- (2008) Min Dong et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now